Amalya Sargsyan

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Amalya Sargsyan
Feb 17, 2025, 05:06 | Blog
The Second Global OncoThon: Highlights Part 4
OncoDaily and the International Society of Pediatric Oncology (SIOP)  hosted the Second Global OncoThon, a 24-hour virtual event on February 15,…
Feb 15, 2025, 16:26 | Blog
International Childhood Cancer Day 2025
International Childhood Cancer Day (ICCD), February 15, calls to action to raise awareness about childhood cancer and…
Feb 4, 2025, 18:18 | Blog
Amalya Sargsyan: Presenting the latest approvals in metastatic gastric cancer treatment at the 5th Armenian National Oncology Congress
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared on LinkedIn: "Eight months…
Feb 1, 2025, 13:00 | Science
Elen Baloyan: Excited to share our RWE on pancreatic cancer in Armenia
Elen Baloyan, Oncology Fellow at Yeolyan Hematology and Oncology Center and Managing Editor of OncoDaily,…
Jan 30, 2025, 15:18 | Blog
Amalya Sargsyan: I’ll be speaking on a topic very close to my heart at the ESMO Sarcoma and Rare Cancer Congress
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared a post on LinkedIn:…
Jan 27, 2025, 17:02 | Insight
Best of BGICC 2025: 17th Breast-Gynecological International Cancer Conference
Breast Gynecological and Immunooncology International Cancer Conference (BGICC) 2025 is took place on January 23-24,…
Jan 24, 2025, 15:32 | Insight
Highlights from the 17th BGICC: Day 1 of Breast-Gynecological International Cancer Conference
Breast Gynecological and Immunooncology International Cancer Conference (BGICC) 2025 is taking place on January 23-24,…
Jan 24, 2025, 13:04 | Insight
Amalya Sargsyan: BGICC 2025 kicked off with 5000 attendees in Cairo
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared a post on X:…
Jan 21, 2025, 14:48 | Dialogues
Clinical Trials in Small Populations: Challenges and Opportunities
In the inaugural event of the Global Cancer Movement, initiated by OncoDaily, Amalya Sargsyan, Medical…
Jan 13, 2025, 09:18 | Dialogues
Cell Therapies in Sarcomas: Lete-cel in Synovial Sarcoma and MRCLs
In this episode of OncoDaily, Dr. Sandra D'Angelo, a renowned sarcoma expert from Memorial Sloan…
Dec 22, 2024, 04:49 | Blog
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Amalya Sargsyan, Medical Oncologist at Yeolyan Center, shared a post on LinkedIn: "New Podcast Alert.…
Dec 8, 2024, 14:03 | Blog
Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer - Day 2
Welcome to Day Two of the Global Cancer Movement: Challenging the Status Quo in Colorectal…
Dec 8, 2024, 10:09 | Blog
Amalya Sargsyan: An incredible learning experience at National Cancer Institute of Milan
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, posted on Facebook: "Spent the…
Nov 3, 2024, 11:54 | Dialogues
Zolbetuximab: From Promising Drug to FDA Approval | Exclusive Interview with Astellas
In this episode of OncoDaily, Dr. Moitreyee Chatterjee-Kishore and Tomoko Nakajima from Astellas Pharma join…
Nov 1, 2024, 15:29 | Blog
Amalya Sargsyan: Super happy for the CityU iGEM Team on winning Gold at iGEM Competition 2024
Amalya Sargsyan, Medical Oncologist at Yeolyan Center, shared a post on LinkedIn: "Super happy for the…
Sep 24, 2024, 16:52 | Blog
Assessment of the safety and efficacy of Balstilimab in combination with Botensilimab for NSCLC - Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: ''Assessment of the safety and efficacy…
Sep 21, 2024, 14:10 | Blog
Difficulties faced by cancer patients and healthcare professionals in Armenia - CityU iGEM
CityU iGEM shared a post on LinkedIn: ''Exciting update. Not so long ago we had…
Sep 19, 2024, 14:44 | Blog
Amalya Sargsyan: Abeid Athman was awarded Best Poster at ESMO24
Amalya Sargsyan posted on X: "Hugee Congraaats to my friend Abeid Athman who was awarded…
Sep 17, 2024, 16:28 | Blog
Amalya Sargsyan: DestinyGastric03 trial results and HER2+ treatment insights at ESMO24
Amalya Sargsyan posted the following on X: “Great insights from Yelena Janjigian, MD at ESMO24!…
Sep 17, 2024, 15:09 | Blog
Amalya Sargsyan: Learn about the CTC fellowship program for young oncologists at ESMO24
Amalya Sargsyan shared a post on X: ''Come visit the ESOncology Booth at ESMO24 congress,…
Sep 4, 2024, 11:47 | Dialogues
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
In this episode of OncoDaily Interviews, Dr. Benjamin Schlechter, a distinguished medical oncologist at the…
Aug 2, 2024, 09:31 | Dialogues
Chinese Cancer Drug Set to Transform Global Market: Glecirasib | Most Promising Cancer Drugs 2024
In this exclusive interview with Dr. Andrea Wang-Gillam, we discuss the revolutionary potential of Glecirasib…
Jul 21, 2024, 04:10 | OncoDaily Pulse
OncoDaily Party and Yvonne Award Photos - Part 1
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jul 2, 2024, 17:21 | Blog
Amalya Sargsyan: One of Oncodaily’s top 10 promising drugs is showing great resuts at ESMOGI24
Amalya Sargsyan shared a post by Pashtoon Kasi, on LinkedIn: "Exciting Updates! 𝐁𝐨𝐭𝐞𝐧𝐬𝐢𝐥𝐢𝐦𝐚𝐛 one of OncoDaily's…
Jul 2, 2024, 04:25 | OncoDaily Pulse
OncoDaily Party and Yvonne Award 2024 Photos - Part 2
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jun 29, 2024, 12:49 | Insight
New Paper Alert! Proteogenomic Analysis Identified New Cancer Drug Targets Across 10 Cancer Types
Proteogenomic Analysis Identified New Cancer Drug Targets Across 10 Cancer Types         …
Jun 26, 2024, 08:00 | Insight
New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial
Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…
Jun 24, 2024, 04:49 | Insight
New Paper Alert!- PARP Inhibitor Rucaparib Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer with HRR Mutations
PARP Inhibitor Rucaparib Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer with HRR Mutations Authors: Mark…
Jun 22, 2024, 14:12 | Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
Jun 21, 2024, 17:14 | Blog
Amalya Sargsyan: Opening a new chapter in clinical trials for LMICs
Amalya Sargsyan shared a post on X: "Opening a new chapter in clinical trials for…
Jun 21, 2024, 07:54 | Insight
New Paper Alert! New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers
New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers Authors: Carrie…
Jun 21, 2024, 02:08 | Insight
New Paper Alert! AtezoTRIBE Study
AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…
Jun 21, 2024, 01:37 | Blog
ASCO's participants selected for the 2024 IDEA and IDEA-PC programs
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "We congratulate the participants…
Jun 14, 2024, 01:23 | Insight
New Paper Alert! Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab
Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab Authors: Andrea J. Bullock,…
Jun 11, 2024, 16:03 | Societies
Amalya Sargsyan: Super proud to have Yelena Janjigian as my mentor through the IDEA program
Amalya Sargsyan shared a post on LinkedIn: "Super proud to have Yelena Janjigian as my mentor…
Jun 10, 2024, 15:04 | Societies
Amalya Sargsyan: We felt truly welcomed by the largest oncology community of ASCO
Amalya Sargsyan recently shared a post on LinkedIn: "It was a privilege to meet with…
Jun 3, 2024, 23:46 | Societies
Elen Baloyan: Everything is bigger at ASCO
Elen Baloyan, Medical Oncology Fellow at the Yeolyan Hematology and Oncology Center and the Managing Editor…
May 31, 2024, 16:03 | Career
Amalya Sargsyan: Extremely excited to get my first Conquer Cancer, the ASCO Foundation award
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post by Conquer Cancer,…
May 4, 2024, 12:13 | Insight
New Paper Alert! Understanding MSI and MMR in Urothelial Carcinoma: Systematic Review and Meta-analysis
Understanding MSI & MMR in Urothelial Carcinoma: Systematic Review and Meta-analysis Authors: Elias B A…
May 3, 2024, 14:50 | Insight
New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma
Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma Authors: Matthew D. Robinson, Roseanna Wheatley, Lucy Foster,…
Apr 30, 2024, 11:17 | Insight
New Paper Alert! Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer
Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer Authors: Niklas Klümper, MD,…
Apr 26, 2024, 20:26 | Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
Apr 26, 2024, 17:42 | Insight
New Paper Alert! The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms
The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms Authors:…
Apr 25, 2024, 19:48 | Insight
New Paper Alert! The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with Cancer
The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with…
Apr 25, 2024, 00:51 | Insight
New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…
Apr 23, 2024, 18:57 | Insight
New Paper Alert! Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of the Literature
Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of…
Apr 22, 2024, 19:23 | Insight
New Paper Alert! A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation
A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners…
Apr 22, 2024, 11:11 | Insight
New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…
Apr 21, 2024, 08:05 | Insight
New Paper Alert! Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer
Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer…
Apr 20, 2024, 06:18 | Insight
New Paper Alert! Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer
Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer Authors: David Planchard, Rachel E. Sanborn,…
Apr 19, 2024, 16:30 | Insight
New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance
Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…
Apr 18, 2024, 16:36 | Insight
New Paper Alert! Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy
Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy Authors: Pierre-Louis Cariou,…
Apr 18, 2024, 11:57 | Insight
New Paper Alert! The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based on Microsatellite Instability Status
The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based…
Apr 17, 2024, 13:11 | Insight
New Paper Alert! Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal Cancer: A Real-World Analysis
New Paper Alert: Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal…
Apr 16, 2024, 17:00 | Insight
New Paper Alert! A Novel 3-Gene Expression Score Predicts Immunotherapy Response in Advanced Renal Cell Carcinoma
New Paper Alert! A Novel 3-Gene Expression Score Predicts Immunotherapy Response in Advanced Renal Cell…
Apr 15, 2024, 14:38 | Insight
New Paper Alert! Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response
Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response Authors: Carmine Valenza,…
Apr 15, 2024, 14:01 | Insight
New Paper Alert! How Tumor Biomechanics Shape Metastatic Dissemination of Triple Negative Breast Cancer
How Tumor Biomechanics Shape Metastatic Dissemination of Triple Negative Breast Cancer Authors: Elysse C. Filipe,*…
Apr 15, 2024, 13:34 | Insight
New Paper Alert! Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall Survival Estimates
Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall…
Apr 15, 2024, 10:32 | Insight
New Paper Alert! Erdafitinib Demonstrates Promising Efficacy in FGFR-Altered Solid Tumors: NCI-MATCH Subprotocol K2 Results
Erdafitinib Demonstrates Promising Efficacy in FGFR-Altered Solid Tumors: NCI-MATCH Subprotocol K2 Results Authors: Jun Gong,…
Apr 15, 2024, 04:04 | Blog
Amalya Sargsyan: Proud to see IMMONC spotlighted in ASCO's latest policy statement on global equity in clinical trials
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, posted on LinkedIn: "Extremely proud to…
Apr 14, 2024, 07:51 | Insight
New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach
Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach  Published in Journal for ImmunoTherapy of Cancer,…
Apr 13, 2024, 08:37 | Insight
New Paper Alert! How concurrent Medication Impacts The Outcomes Of Patients Treated with Immune Checkpoint Inhibitors
How concurrent Medication Impacts The Outcomes Of Patients Treated with Immune Checkpoint Inhibitors Published in…
Apr 11, 2024, 16:08 | Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 11, 2024, 14:28 | Insight
New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors
Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors  Authors: Matthew T Campbell,…
Apr 10, 2024, 09:32 | Insight
New Article Alert! New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment
New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment Authors: Mark Yarchoan, Edward…
Apr 8, 2024, 22:37 | Insight
Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…
Apr 8, 2024, 22:24 | Insight
NSCLC's Immune Landscape: A Comprehensive Study of the Tumor Microenvironment
A recent study, “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical…
Apr 8, 2024, 15:24 | Insight
Amalya Sargsyan: Fantastic paper out in AACR Journals on the role of TME in NSCLC
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared on LinkedIn: "Is targeting…
Apr 8, 2024, 14:59 | Blog
Priya Ranganathan: Announcing a series of webinars on research methods, biostatistics, and publishing, as part of the CReDO Workshop
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post by…
Apr 6, 2024, 16:25 | Insight
New Article Alert! FOLFIRI plus durvalumab with or without tremelimumab in advanced gastric or GEJ adenocarcinoma
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal…
Apr 3, 2024, 13:04 | Blog
Amalya Sargsyan: Small team, big goals! This year our Yeolyan Oncology and Hematology Center team had 9 abstracts accepted at ASCO24
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post on…
Mar 8, 2024, 14:50 | Blog
Amalya Sargsyan: Incredible talk on Phase II trial designs by Dr. Mark Krailo during the Cancer Research Methods (Credo) Workshop in Lonavala, India
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post on…
Feb 28, 2024, 18:42 | Drugs
Amalya Sargsyan: Excitement around osimertinib in the NSCLC community
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn: "Huge…
Feb 26, 2024, 11:30 | Career
Amalya Sargsyan has been awarded with prestigious ASCO IDEA Award - Yeolyan Hematology and Oncology Center
Yeolyan Hematology and Oncology Center shared on their LinkedIn page: "We have new achievements in the…
Feb 22, 2024, 23:27 | Blog
Amalya Sargsyan: First approved T cell therapy for solid tumors
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post by Nicholas Restifo,…
Feb 16, 2024, 19:06 | Blog
Amalya Sargsyan: Rally Foundation for Childhood Cancer Research has generously donated $200,000 to support Oncothon
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared on LinkedIn: “On This Day…
Feb 15, 2024, 18:08 | Career
Amalya Sargsyan: An email that every young oncologist imagines getting
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared on LinkedIn: "Not long ago,…
Feb 8, 2024, 16:56 | Blog
IV Armenian Oncology Congress: 6 tweets from Shushan Hovsepyan
Shushan Hovsepyan, Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center,…
Jan 21, 2024, 07:38 | Blog
Amalya Sargsyan: Is it time to consider SBRT plus SOC as the new standard in managing oligoprogressive NSCLC?
Amalya Sargsyan, Medical Oncologist at the Yeolyan Hematology and Oncology Center, shared a post on…
Oct 28, 2023, 16:01 | Blog
Amalya Sargsyan: Prof. Carol Greider won a NOBEL PRIZE but NIH rejected her grant on the same day!
Amalya Sargsyan, Research Fellow at Immune Oncology Research Institute, shared a post on Twitter: "At…
Oct 26, 2023, 18:11 | Blog
Amalya Sargsyan: It was a privilege to be part of the Grant writing school at Milano Bicocca
Amalya Sargsyan and Shushan Hovsepyan, Research Fellows at Immune Oncology Research Institute, shared a post by…
Oct 25, 2023, 19:02 | Insight
Amalya Sargsyan: ESMO23 - Advances in EGFR mutated NSCLC
Amalya Sargsyan, Research Fellow at Immune Oncology Research Institute, shared a post on LinkedIn: "ESMO23:…
All: 82 Posts: 1 - 100
Special Coverage